Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era
Binod Dhakal(Medical College of Wisconsin), Anita D’Souza, David H. Vesole(Hackensack University Medical Center), Omar Dávila(Medical College of Wisconsin), Leona Holmberg, Attaphol Pawarode(University of Michigan), Muzaffar H. Qazilbash(The University of Texas MD Anderson Cancer Center), Mohamed A. Kharfan‐Dabaja(Jacksonville College), Gerhard Hildebrandt(University of Missouri Health System), Nosha Farhadfar(University of Florida Health), Cindy Lee(University of Toronto), Hemant S. Murthy(University of Florida), Shaji Kumar(Mayo Clinic), Raphael Fraser(University at Buffalo, State University of New York), Saulius Girnius(TriHealth), Saurabh Chhabra(Medical College of Wisconsin), Yago Nieto(The University of Texas MD Anderson Cancer Center), Parameswaran Hari(Medical College of Wisconsin), Asad Bashey, Jan Černý(Worcester Memorial Hospital), Hillard M. Lazarus(University Hospitals of Cleveland), César O. Freytes(CHRISTUS Transplant Institute), Sagar S. Patel(University of Utah), Shahrukh K. Hashmi(Mayo Clinic), Reinhold Munker(Louisiana State University), Robert F. Cornell(Dana-Farber Cancer Institute), Lohith Bachegowda(The University of Texas MD Anderson Cancer Center), Jesús G. Berdeja(Tennessee Oncology), Amer Assal(Columbia University Irving Medical Center), Sachiko Seo(National Cancer Center Hospital East), Nina Shah(The University of Texas MD Anderson Cancer Center), Yvonne A. Efebera(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Taiga Nishihori(Moffitt Cancer Center), Abraham S. Kanate(HonorHealth), Sherif M. Badawy(Northwestern University), Wilson I. Gonsalves(Mayo Clinic in Arizona), Qaiser Bashir(The University of Texas MD Anderson Cancer Center), Richard F. Olsson(AstraZeneca (Netherlands)), Robert Peter Gale(Imperial College London), Keith Stockerl‐Goldstein(City Of Hope National Medical Center), Miguel Ángel Díaz(Hospital Infantil Universitario Niño Jesús), Amr Hanbali(King Faisal Specialist Hospital & Research Centre), Kenneth R. Meehan(Dartmouth–Hitchcock Medical Center), Jeffrey Schriber, Jean A. Yared(University of Maryland, Baltimore), Ruthlee-Lu Bayer(North Shore University Hospital), Melhem Solh(Johns Hopkins Hospital)
Cited by 41
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k